SYNGENE INTERNATIONAL LIMITED UNIT III BLOCK S. 14

Company Introduction:

Syngene International Limited is a prominent integrated research, development, and manufacturing organization (CRDMO) based in India. The company provides comprehensive scientific services spanning discovery, development, and manufacturing to global pharmaceutical, biotechnology, nutrition, animal health, and consumer goods companies. Their offerings include discovery chemistry, discovery biology, process research and development, cGMP manufacturing, and formulation development. Syngene operates state-of-the-art laboratories and manufacturing facilities, supporting clients through various stages from early-stage research to commercial production. UNIT III BLOCK S. 14 likely refers to one of their specific operational sites or blocks within their extensive research and manufacturing infrastructure.

Factory or Trader:

Factory.

SYNGENE INTERNATIONAL LIMITED UNIT III BLOCK S. 14 provides contract research, development, and manufacturing services to pharmaceutical, biotechnology, nutrition, animal health, and consumer goods companies. Their offerings include:

Discovery Services:

Medicinal Chemistry

In Vitro Biology

In Vivo Pharmacology

Target Identification and Validation

Lead Generation and Optimization

Development Services:

API Process Development

Analytical Development

Formulation Development

Pre-clinical and Clinical Manufacturing

Stability Studies

Bioanalytical Services

Manufacturing Services:

Clinical and Commercial Scale Manufacturing of APIs (Active Pharmaceutical Ingredients)

Drug Product Manufacturing

Biologics Services:

Cell Line Development

Process Development

Analytical Development

Manufacturing of Biologics (e.g., antibodies, proteins)